SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-23-024571
Filing Date
2023-03-30
Accepted
2023-03-30 15:12:26
Documents
72
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2022_bioessence.htm   iXBRL 10-K 727994
2 DESCRIPTION OF SECURITIES f10k2022ex4-2_bioessence.htm EX-4.2 5662
3 CERTIFICATION f10k2022ex31-1_bioessence.htm EX-31.1 9975
4 CERTIFICATION f10k2022ex31-2_bioessence.htm EX-31.2 9920
5 CERTIFICATION f10k2022ex32-1_bioessence.htm EX-32.1 4737
6 CERTIFICATION f10k2022ex32-2_bioessence.htm EX-32.2 4852
  Complete submission text file 0001213900-23-024571.txt   4135770

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cik00001723059-20221231.xsd EX-101.SCH 69492
8 XBRL CALCULATION FILE cik00001723059-20221231_cal.xml EX-101.CAL 39848
9 XBRL DEFINITION FILE cik00001723059-20221231_def.xml EX-101.DEF 216657
10 XBRL LABEL FILE cik00001723059-20221231_lab.xml EX-101.LAB 467178
11 XBRL PRESENTATION FILE cik00001723059-20221231_pre.xml EX-101.PRE 225850
66 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022_bioessence_htm.xml XML 347682
Mailing Address 8 STUDEBAKER DRIVE IRVINE CA 92618
Business Address 8 STUDEBAKER DRIVE IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

IRS No.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56263 | Film No.: 23780118
SIC: 2834 Pharmaceutical Preparations